Clinical Trials Directory

Trials / Unknown

UnknownNCT02825095

Management of Malignant Pleural Effusion - Indwelling Pleural Catheter or Talc Pleurodesis

Management of Malignant Pleural Effusion - Indwelling Pleural Catheter or Talc Pleurodesis ; a Prospective Randomized Controlled Study.

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Rambam Health Care Campus · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Prospective study of the effect of Talc Pleurodesis vs. Indwelling Pleural catheter in treatment of patients with malignant pleural effusion

Detailed description

Randomized prospective study that will include 120 patients with malignant pleural effusion with high rate of accumulation; less than one month, The patients will be divided randomly for two groups, each group 60 patients, the first group will undergoes talc pleurodesis, the second group will undergoes Indwelling Pleural catheter insertion. The two groups will be followed up for one year, starting at the time of intervention, after 14 days of intervention, after 30 days of intervention, once monthly for one year. The patients will be evaluated according to the rate of complication; need for further intervention in each group, improvement of the quality of life, respiratory improvement, radiological evaluation based on chest Xray findings, rate and duration of admissions that are related to pleural effusion during the year of study.

Conditions

Interventions

TypeNameDescription
PROCEDURETalc Pleurodesischest tube type PIGTAIL 10 - 14 Fr will be inserted to the pleural space. In case of fluid discharges less than 250 cc/24, talc pleurodesis will be performed
PROCEDUREIndwelling Pleural CatheterIndwelling Pleural Catheter type PLEURAX will be inserted to the pleural space. the patients will be discharged with the pleural catheter.
PROCEDUREchest ultrasoundAll insertion of a chest drain will be guided by ultrasound
DRUGLocal anesthesiaInserting a chest drain will be after local anesthesia with 10-20 mL of Lidocaine hydrochloride 20MG/ML - Esracain injection 2%
PROCEDUREChest Tubechest tube type PIGTAIL 10 - 14 Fr will be inserted to the pleural space. In case of fluid discharges less than 250 cc/24, talc pleurodesis will be performed

Timeline

Start date
2016-08-01
Primary completion
2017-05-01
Completion
2017-08-01
First posted
2016-07-07
Last updated
2016-07-07

Source: ClinicalTrials.gov record NCT02825095. Inclusion in this directory is not an endorsement.